This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Korea Research Institute of Standards and Science. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Ri Mi Lee
Introduction
Ri Mi Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of drug screening through his innovative methods. With a focus on enhancing the efficiency of drug discovery, his work has implications for medical research and pharmaceutical development.
Latest Patents
Ri Mi Lee holds a patent for a method of screening drugs. This method involves measuring the capacitance of an endothelial cell layer at a frequency range of 100 Hz to 5 kHz. The technique is designed to screen drugs that affect paracellular permeability of the endothelial cell layer or those that penetrate through a paracellular path. This innovative approach has the potential to streamline the drug development process.
Career Highlights
Throughout his career, Ri Mi Lee has worked with esteemed organizations such as the Korea Research Institute of Standards and Science and Sugentech, Inc. His experience in these institutions has allowed him to refine his research skills and contribute to advancements in drug screening technologies.
Collaborations
Some of his notable coworkers include Dong Hyun Jo and Jeong Hun Kim. Their collaborative efforts have likely enriched the research environment and fostered innovation in their respective fields.
Conclusion
Ri Mi Lee's contributions to drug screening methodologies exemplify the importance of innovation in the medical field. His work not only advances scientific understanding but also holds promise for future developments in pharmaceuticals.